Renal Denervation in the Real World – Practical Guidance for New Users: On-demand

Published: 25 April 2022

  • Views:

    Views Icon 3391
  • Likes:

    Heart Icon 7

Overview

Full programme

Part of

Overview

More from this programme

Seeing is Believing: The Edwards Mitral and Tricuspid Transcatheter Portfolio – On-demand Broadcast

09

Nov

2021

16:30

GMT

Webinar

Overview

This broadcast will bring together 8 leading experts for 90 minutes of the highest-quality, interactive case-based learning in the field of Mitral and Tricuspid repair. Didier Tchétché (Clinique Pasteur, Toulouse, FR) will chair proceedings, Philipp Lurz (Heart Center Leipzig) will lead scientific content, engaging a world-renowned faculty for a series of thought-provoking and informative case presentations, opinions and debate.

For further details of the live broadcast, watch the below video:

 

 

Against the backdrop of a PASCAL MR Live Case under the direction of operator Philipp Lurz and his team (Heart Center Leipzig, DE), this broadcast will examine key features and applications of the PASCAL platform. Dr Sam Dawkins (John Radcliffe Hospital, UK) will explore its practical application for MR, Dr Nicole Karam (European Hospital Georges Pompidou, FR) for TR; whilst Dr Andreas Ruck (Karolinska University Hospital, SE) will provide additional insight with a case-based review of its successful, safe application for Tricuspid Valve repair. Prof Jörg Hausleiter (Ludwig-Maximilians Universitat, Munich, DE) will look to the future of TR treatment, with a review of the EVOQUE replacement system. Prof Michael Böhm will provide his perspective from the HF expert through the discussions.

 

With live audience questions and polls, this dynamic, free-to-attend broadcast will challenge thinking, be case-based, and demonstrate real-world value for improving patient-based outcomes.

Performed By:

Didier Tchétché

Didier Tchétché

Philipp Lurz

Philipp Lurz

Peter Lüdike

Peter Lüdike

Nicole Karam

Nicole Karam

Andreas Rück

Andreas Rück

Sam Dawkins

Sam Dawkins

Jorg Hausleiter

Jorg Hausleiter

Michael Böhm

Michael Böhm

Faculty Biographies

Didier Tchétché

Didier Tchétché

Didier Tchétché, (Clinique Pasteur, Toulouse, France) Graduated from the University of Paris V where Dr Tchétché obtained his post-graduate diploma of cardiovascular pathology in 2004. From 2004 to 2005, he completed a 12-month fellowship period in the Hemodynamic and Interventional Cardiology department of Clinique Pasteur in Toulouse and from 2005 to 2007 he was Head Assistant at the intensive care unit of Bichât Hospital in Paris.

In 2008, he joined the interventional cardiovascular group in Clinique Pasteur, Toulouse, and he is currently Head of the Structural programme with an experience of more than 5000 TAVI procedures. His main areas of interest are coronary interventions and valvular heart disease. He has been actively involved in many clinical trials involving new technologies and devices in the field of interventional cardiology.

View full profile
Philipp Lurz

Philipp Lurz

Prof Philipp Lurz is Deputy Head of the Department at Heart Center Leipzig, Germany, a position he has held since 2018. Previously, Prof Lurz was a Clinical Research Fellow at Great Ormond Street Hospital for Children NHS Foundation Trust. He completed his education at the University of Leipzig, and is a member of the German Society of Cardiology. Prof Lurz is widely published in leading international peer-reviewed journals.

View full profile
Peter Lüdike

Peter Lüdike

Prof Peter Lüdike is Senior Physician of the Heart Failure and Intensive Care section in the Department of Cardiology and Vascular Medicine at the West German Heart and Vascular Center, University Hospital Essen. He achieved Venia legendi for internal medicine in 2018 and was appointed as Full Professor for heart failure in 2020. His research interests include intensive care medicine, emergency medicine, heart failure, mitral valve disease and the role of macrophage migration inhibitory factor in the development of ischaemic heart disease.

View full profile
Nicole Karam

Nicole Karam

Prof Nicole Karam is an associate professor in the Department of Cardiology at the European Hospital Georges Pompidou. She specializes in interventional cardiology and performs both coronary and valvular percutaneous surgeries, as well as research in Cardiovascular Epidemiology at the French National Institute of Health and Medical Research.

After starting her medical studies at Saint-Joseph University in Beirut, she moved to Paris in 2010 and specialized in Interventional Cardiology. Subsequently, she trained in a highly specialized center for valvular heart disease in Munich, Germany, where she learned new techniques in percutaneous valvular interventions that she later brought back to Georges Pompidou Hospital.

Prof Karam is an active member and a fellow of the European Society of Cardiology, and a member of the steering committee of the Women’s European Association of Percutaneous Cardiovascular Interventions. 

View full profile
Andreas Rück

Andreas Rück

Dr Andreas Rück is the head of the Transcatheter Aortic Valve Implantation (TAVI) program at Karolinska University Hospital – Stockholm, Sweden and the chairman of the Swedish Percutaneous Valve Registry (a registry within the Swedish Heart Registries SWEDEHEART). He is member of the steering group of SWEDEHEART and of the Working group for PCI and Valve Interventions within the Swedish Society of Cardiology. His clinical specialties include PCI and percutaneous valve implantation.

View full profile
Sam Dawkins

Sam Dawkins

Dr Dawkins is a Consultant Cardiologist at the John Radcliffe Hospital in Oxford. He has expertise in general cardiology, interventional cardiology and is a specialist in valve intervention, including TAVI and MitraClip. 

View full profile
Jorg Hausleiter

Jorg Hausleiter

An interventional cardiologist expert in the field of valvular and coronary heart diseases, Prof Dr Jorg Hausleiter is Professor of Medicine and the Deputy Clinic Director at the Ludwig-Maximilians Universitat in Munich, Germany. He is invested in bringing new and innovative technologies into clinical practice.

View full profile
Michael Böhm

Michael Böhm

Dr Michael Böhm performed his medical training at the Medical School of Hannover in Germany. Residency in Internal Medicine and fellowships in Cardiology at the Ludwig Maximilians-Unversity in Munich/Germany at the Klinikum Großhadern; Heisenberg Graduate of the Deutsche Forschungsgemeinschaft; Assistant and Associate Dr of Internal Medicine and Cardiology at the Universität zu Köln in Germany.

Dr Böhm is Director of the Klinik für Innere Medizin III and Chief of Cardiology at the University of the Saarland in Homburg/Saar in Germany. Dr Böhm's special interest includes pathophysiology and therapy of heart failure. Particular, he is involved in studies on signal transduction in the failing heart and in vascular biology. Dr Böhm has been the principal investigator in several international multicenter studies. He has written more than 350 original papers, book chapters and review articles. He has obtained several awards of scientific societies. Dr Böhm is a reviewer for most recognized scientific journals in the cardiovascular field and chief editor Clinical Research in Cardiology. He is president of the German Society of Cardiology.

Dr Michael Böhm is an Editorial Board member of Cardiac Failure Review.

View full profile

Complete Revascularization – The New Standard in STEMI Patients: What is the Role of Coronary Physiology Today?

20

Apr

2021

17:00

BST

Webinar

Overview

This broadcast focuses on the importance of performing full revascularization (recognized as the new standard vs culprit in STEMI patients) and the benefits of this guided by physiology to maximise patient outcomes.

Dr Gabor Toth (Graz, Austria) will moderate peers Dr Pieter Smits (Rotterdam, Netherlands) and Dr Zsolt Piroth (Budapest, Hungary) in a session based on clinical cases showing the range of criteria to decide the best interventional strategy, whilst presenting how the technological features of the OptoWire III pressure guidewire can help operators during a PCI in STEMI patients.

This event will be interactive, with live polling on key questions, and a Q&A for faculty to share their experience and provide expert insight to live audience questions.

Performed By:

Pieter C Smits

Pieter C Smits

Moderated By:

Gábor G Tóth

Gábor G Tóth

Faculty Biographies

Pieter C Smits

Pieter C Smits

Dr Pieter C Smits is Director of the Interventional Cardiology Department of Maasstad Hospital Rotterdam and board member of the Dutch Heart Registration. 

Dr Smits completed his medical training in Utrecht/Nieuwegein and joined the staff at the Cardiology Department of the University Hospital Utrecht. In 1999 he became an interventional cardiologist at the Thorax Center of the Erasmus Medical Center in Rotterdam.

View full profile
Gábor G Tóth

Gábor G Tóth

Dr Gabor G Toth is an Interventional Cardiologist at the University Heart Centre Graz, Austria. He graduated from the University of Szeged, Hungary in 2007, and trained at the the Hungarian Institute of Cardiology, Budapest, and the Cardiovascular Research Centre Aalst, Belgium. His special interests include interventional cardiology and coronary physiology.

View full profile

Coronary Physiology – Can a New Pressure Guidewire Design Expand Adoption?

25

Mar

2021

14:00

GMT

Webinar

Overview

After FAME and iFR, OptoWire III promises to be a technological innovation to support both a significant increase in adoption and the implementation of the recommendations of clinical studies and medical societies.

This case-based webinar, at 3pm CET / 2pm GMT, examines the barriers limiting the adoption of physiology in the real world and reviews how OptoWire III empowers physicians to overcome them.

Cases discussed will address the following:

- Calcified lesions, bifurcations

- Ease of use, fast procedure, reliable data for COVID times

- Comorbidities (alteration of renal function, need to reduce contrast and PCI duration)

 

This educational webinar will comprise two experts in complex PCI (Dr Pasi Karjalainen, Helsinki, Finland, and Dr Evald Høj ChristiansenAarhus, Denmark) each presenting a case – addressing bifurcations and calcified lesions respectively – to best highlight their experiences with the OptoWire III in supporting a complex physiology-guided procedure and simplifying the case.

Proceedings will be moderated by Dr Tim Schaufele, Bern, Switzerland, who will facilitate the discussion around the two cases and lead the live audience Q&A.

Performed By:

Evald Høj Christiansen

Evald Høj Christiansen

Moderated By:

Faculty Biographies

Evald Høj Christiansen

Evald Høj Christiansen

Dr Evald Høj Christiansen is an Associate Professor in the Cardiology Department of Aarhus University Hospital. He is an interventional cardiologist with 15 years' of experience in the field. His main interest is chronic total occlusions, bifurcations, coronary imaging, physiologic evaluations of coronary artery disease, and TAVR. He has performed a series of studies in this area and has conducted many clinical trials.

View full profile

How to Perform PCI in Coronary Bifurcation Lesions in 2021

16

Mar

2021

17:00

GMT

Webinar

Overview

In this live webinar, that commences at 6pm CET / 5pm GMT, Prof Robert Gil, Head of the Department of Invasive Cardiology of the Clinical Hospital of the Ministry of the Interior and Administration (MSWiA) in Warsaw, provides an overview on the percutaneous treatment of Coronary Bifurcations, from epidemiology and prevalence, to relevant clinical evidence, to classifications, diagnostic assessment and treatment techniques.

With a special focus on techniques and technologies, Prof Gil will combine presentation and discussion to illustrate practice and enhance educational value. He will also address audience questions to maximise the interactive experience.

The themes covered in this webinar are further explored by Prof Gil's white paper entitled 'Performing PCI in Coronary Bifurcation Lesions in 2021'.

Performed By:

Robert Gil

Robert Gil

Faculty Biographies

Robert Gil

Robert Gil

Robert Gil is Head of the Department of Invasive Cardiology of the Clinical Hospital of the Ministry of the Interior and Administration (MSWiA) in Warsaw, Poland, a position he has held since 2001.

Graduating from the Pomeranian Medical University in Szczecin, since 2001 Prof Gil has been part of the Expert Team handling accreditation in cardiology, as appointed by the Polish Minister of Health. In addition, since 2002 he has been a Consultant of Healthcare for cardiology for the Ministry of the Interior and Administration. Prof Gil has wide scientific and research interests including the evaluation of atherosclerotic plaque characteristic and distribution, coronary stenosis significance, treatment of complex lesions, notably bifurcation lesions using invasive diagnostic techniques that include IVUS, OCT or iFR/FFR.

Prof Gil has held a number of key positions at leading associations and professional bodies. In October 2015 he was elected a Member of the Board of the Polish Cardiac Society. He has authored or co-authored over 200 publications to leading peer-reviewed journals, many of which with a high impact factor. In addition Prof Gil lectures and presents widely at international conferences in the clinical electrophysiology and invasive cardiology spheres. He served as co-author of the guidelines of the Invasive Cardiology Section of the Polish Cardiac Society and, between 1997 and 2004, served as Chair of the Invasive Cardiology Section (Working Group) of the Polish Cardiac Society.

View full profile

A Peek into the Future – Repair and Replacement of the Mitral and Tricuspid Valves with the Edwards Portfolio

18

Mar

2021

16:00

GMT

Webinar

Overview


This webinar, at 5pm CET / 4pm GMT, will bring together an internationally-respected faculty to review the PASCAL platform focusing on the recently CE mark approved PASCAL Ace implant system for the treatment of mitral and tricuspid regurgitation.

Through a combination of case presentations, discussion, and a live case procedure from Heidelberg University Hospital, the theory- and practical-based agenda has been formulated to best support everyday practice and enhance patient outcomes.

Pipeline products for tricuspid transcatheter replacement from Edwards Lifesciences will be shown and briefly discussed.

Performed By:

Nicolas M Van Mieghem

Nicolas M Van Mieghem

Peter Lüdike

Peter Lüdike

Philipp Lurz

Philipp Lurz

Ralph Stephan von Bardeleben

Ralph Stephan von Bardeleben

Philip Raake

Philip Raake

Faculty Biographies

Nicolas M Van Mieghem

Nicolas M Van Mieghem

Personal History

From an early age, Professor Nicolas Maria Van Mieghem decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them. I wanted to enter a profession that would channel my energy— I was always a busy child,” he says. 

A budding athlete, he was a member of Belgium’s national swimming team but soon realized that medicine was his true calling. His father was a general cardiologist and one of his biggest influences early in his career.

Professor Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. 

His mantra is mens sana in corpore sano (a healthy mind in a healthy body). He remains an avid swimmer and cyclist and follows a number of professional sports. “Like all Belgians, I love to watch the big cycling events—the classic cycle races, the Tour de France, the Giro d’Italia, the Vuelta a España,” he says. 

Van Mieghem believes that a great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors. 


 

Academic History

 

In 2007, Professor Van Mieghem obtained his medical and cardiology degrees at the Catholic University of Leuven, Belgium. He completed fellowships in interventional cardiology in Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, US and Erasmus Medical Center, Rotterdam, the Netherlands.2 His PhD focused on transcatheter valve therapies.3

His current research focuses on cerebral embolic protection during TAVI and the search for improved large bore closure devices. He works actively in expanding TAVI indications, most notably TAVI as a means to further unload the left ventricle in heart failure patients with moderate aortic stenosis (the TAVR UNLOAD trial). Professor Van Mieghem is also involved in the development and dispersion of mechanical circulatory support (MCS) devices as well as transcatheter mitral and tricuspid repair techniques. In terms of imaging and preprocedural planning, his research has covered computed tomography (CT)-derived 3D modelling and printing.

Professor Van Mieghem has received institutional research grant support from Abbott Vascular, Boston Scientific, Edwards Lifesciences, Medtronic, Daiichi-Sankyo, PulseCath BV and Abiomed.7

 

Career Overview

After his fellowships, Professor Van Mieghem joined the department of interventional cardiology at the Thorax Centre, Erasmus Medical Center, as a senior staff member in February 2010. He is now working there as a Full Professor of Interventional Cardiology.2

As well as his involvement in the percutaneous coronary interventions and structural heart programs, he has published and co-authored over 350 scientific papers in peer-reviewed journals.4 Professor Van Mieghem is a principal investigator and steering committee member in multiple ongoing international trials, evaluating various coronary and transcatheter valve technologies.3 He is a Fellow of the European Society of Cardiology (FESC) and is currently Medical Director of the department of Interventional cardiology at the Thorax Centre.3

 

Career Timeline

  • 2008 - 2009: Fellow, Interventional Cardiology, Lenox Hill Hospital
  • 2010: Joined the senior staff, Interventional Cardiology, Thorax Centre, Erasmus MC
  • 2014: Clinical Director, Interventional Cardiology, Erasmus MC
  • 2019 - Present: Full Professor, Interventional Cardiology, Erasmus MC
  • Present: Medical Director, Interventional Cardiology, Thorax Centre 

 

Areas of Speciality4

  • Interventional Cardiology
  • Transcatheter Heart Valve Interventions

 

Sources

  1. https://cardiovascularnews.com/nicolas-van-mieghem/
  2. https://esc365.escardio.org/Person/418700-dr-van-mieghem-nicolas 
  3. https://www.radcliffecardiology.com/authors/nicolas-m-van-mieghem 
  4. https://www.ecri-trials.com/faculty/nicolas-van-mieghem/ 
  5. https://www.cardialysis.com/core-lab/supervising-cardiologists/ 
  6. https://www.worldcat.org/title/transcatheter-aortic-valve-therapies-from-cutting-edge-to-mainstream-catheter-gebonden-aortaklep-implantatie/oclc/892053833 
  7. https://www.jacc.org/doi/pdf/10.1016/j.jcin.2020.12.021 

 

 Prof Van Mieghem is on the ICR3 Editorial Board.

 

View full profile
Peter Lüdike

Peter Lüdike

Prof Peter Lüdike is Senior Physician of the Heart Failure and Intensive Care section in the Department of Cardiology and Vascular Medicine at the West German Heart and Vascular Center, University Hospital Essen. He achieved Venia legendi for internal medicine in 2018 and was appointed as Full Professor for heart failure in 2020. His research interests include intensive care medicine, emergency medicine, heart failure, mitral valve disease and the role of macrophage migration inhibitory factor in the development of ischaemic heart disease.

View full profile
Philipp Lurz

Philipp Lurz

Prof Philipp Lurz is Deputy Head of the Department at Heart Center Leipzig, Germany, a position he has held since 2018. Previously, Prof Lurz was a Clinical Research Fellow at Great Ormond Street Hospital for Children NHS Foundation Trust. He completed his education at the University of Leipzig, and is a member of the German Society of Cardiology. Prof Lurz is widely published in leading international peer-reviewed journals.

View full profile
Ralph Stephan von Bardeleben

Ralph Stephan von Bardeleben

Dr Ralph Stephan von Bardeleben is the Head of the Center of Structural Heart Disease Interventions and the Heart Valve Center in Mainz, Germany. Following the completion of his medical education at the University of Mainz and the University of California in San Francisco, US, Dr Bardeleben trained as both an imager and interventional cardiologist. Since 2004 he has served as Head of the CV imaging department. A regular speaker at international events, Dr Bardeleben's department has played key roles in a number of early 'in-man' implantations and other international trials.

View full profile
Philip Raake

Philip Raake

Prof Philip Raake is a senior physician who leads the HFU centre at the Department of Cardiology at Heidelberg University Hospital. He also runs the Interventional HF programme.

Prof Philip Raake attended medical school at the Ludwig-Maximilians University in Munich. Between 2006 and 2008, Prof Raake worked at the Center for Translational Medicine, under the direction of Prof Walter Koch, at the Thomas Jefferson University, Philadelphia.

In 2008 Prof Raake returned to Germany, where his established the first university Advanced Heart Failure Unit in Germany focusing on optimised care in advanced HF. He has authored or co-authored several papers in leading peer-reviewed journals on HF basic molecular mechanisms, and clinical aspects of advanced HF. He serves on several working groups for the German Society for Cardiology and the German Federal Physicians Association.

View full profile

Renal Denervation in the Real World: Practical Guidance for New Users

19

Apr

2022

16:00

BST

Webinar

Overview

During this unique broadcast, Radcliffe Medical Education brings together a globally-renowned European and American faculty to share best practices on resistant hypertension and renal denervation (RDN). If you manage patients with resistant hypertension – whether you treat directly or regularly refer patients to hypertension specialist services – this expert guidance will distil the most important practical points on identifying candidates for RDN. The aims of this broadcast are to draw attention to the current scale of resistant hypertension in the hypertensive population and to impart a sound understanding on appropriate patient selection for RDN.

Prof Roland Schmieder (University Hospital Erlangen, DE) leads proceedings, and is joined by Prof Michel Burnier (University Hospital of Lausanne, CH), Prof Cara East (Texas A&M College of Medicine, US) and Prof Konstantinos Tsioufis (University of Athens, GR) for a series of insightful presentations, discussions and live Q&A.

This broadcast is supported by an unrestricted educational grant from Medtronic.

Performed By:

Roland E Schmieder

Roland E Schmieder

Michel Burnier

Michel Burnier

Faculty Biographies

Roland E Schmieder

Roland E Schmieder

Roland E Schmieder is a Professor of Internal Medicine, Nephrology and Hypertension, Head of the Clinical Research Centre and Vice Chair of the Department of Nephrology and Hypertension at the University Hospital Erlangen, Germany. He also directs the Institute of Preventative Medicine at the University Erlangen-Nuremberg and the Community Hospital Nuremberg. Professor Schmieder is a member of numerous professional societies and committees, and is a Fellow of the American College of Physicians (ACP) and the American College of Cardiology (ACC). He is on the international Editorial Board of the American Journal of Hypertension, the Journal of Human Hypertension and the Journal of Nephrology, among other scientific journals. Professor Schmieder received his post-graduate medical training in nephrology, cardiology and hypertension at the University Hospital of Bonn, and then at the Alton Ochsner Foundation, New Orleans. He graduated in medicine from the University of Tübingen, Germany.

View full profile
Michel Burnier

Michel Burnier

Michel Burnier is a Professor of Medicine and Head of the Division of Nephrology and Hypertension Consultation at the University Hospital of Lausanne in Switzerland. He is a member of several Swiss and international societies in the field of nephrology and hypertension. He is a member of the Scientific Council of the European Society of Hypertension (ESH) and a committee member of the Swiss Society of Hypertension. Professor Burnier is President Elect of the Swiss Society of Nephrology, President of the ethical review board of the University of Lausanne and a Board Member of Swissmedic, the Swiss Agency for Therapeutic Products. He is on the Editorial Board of several journals, including Hypertension and Blood Pressure. Professor Burnier trained in internal medicine and nephrology in Lausanne and at the University of Colorado Health Science Centre.

View full profile

The Key to the Castle: Revolutionizing Transseptal Access for Structural Heart Procedures

16

Feb

2022

16:00

GMT

Webinar

Overview

Transseptal puncture (TSP) plays an increasingly significant role in left sided structural heart procedures. Often underestimated, operators might run into difficulties, especially in presence of complex septal anatomies (e.g. fibrotic, floppy septum, plugs etc.).

Learn from an expert panel as they discuss the evolution of left heart access and the techniques and tools they’ve implemented to improve procedural efficiency and optimize patient outcomes. Through illustrative case examples and lively panel discussion, experts will share their step-by-step clinical workflows and latest tools for efficient and precise transseptal puncture, tips for overcoming challenging scenarios, and novel approaches to structural heart procedures with reduced use of fluoroscopy.

 

 

PRM-00870

Performed By:

Ole De Backer

Ole De Backer

Sagar Doshi

Sagar Doshi

Christoph Hammerstingl

Christoph Hammerstingl

Adnan Nadir

Adnan Nadir

Faculty Biographies

Ole De Backer

Ole De Backer

Prof Dr Ole De Backer is an internationally renowned interventional cardiologist working at Rigshospitalet, Copenhagen University Hospital, Denmark and is an expert in structural heart interventions – among others transcatheter heart valve interventions, percutaneous left atrial appendage closure and thoracic endovascular aortic repair. Special areas of interest are the development and adoption of a fully percutaneous, minimal invasive approach for different structural heart interventions and the use of advanced cardiac imaging tools for planning and guidance of these interventions. He is actively involved and leading several research projects in the field of transcatheter heart valves and percutaneous left atrial appendage closure. 

View full profile
Sagar Doshi

Sagar Doshi

Dr Sagar Doshi is Director of the TAVI program at the Queen Elizabeth Hospital in Birmingham where he was appointed to a consultant post in 2005. He was awarded a British Heart Foundation Junior Research Fellowship and undertook his MD at the Wales Heart Research Institute. He was awarded a scholarship to undertake an Interventional Cardiology Fellowship at the prestigious Mount Sinai Hospital, New York, USA.  He has proctored TAVI cases in the UK, Japan and the USA. He has over 70 scientific publications and is an Honorary Senior lecturer at Birmingham Medical School.

View full profile
Christoph Hammerstingl

Christoph Hammerstingl

Prof Dr Christoph Hammerstingl is head of the department of Internal Medicine and Cardiology at the Eduardus Hospital in Cologne. He started his career at the University Hospital in Bonn, where he established interventional echocardiography since 2010 for the treatment of mitral and tricuspid valve disease. As an interventionalist he proctored structural cases all over Europe and North America. He has over 150 scientific publications focussed on the outcomes of minimal invasive therapies of the AV valves, interventional and medical strategies for stroke prevention.

View full profile
Adnan Nadir

Adnan Nadir

Dr Adnan Nadir is a consultant in interventional cardiology. He is an expert on structural heart disease interventions with a focus on transcatheter heart valve interventions. He graduated with top honours from medical school and completed his extensive medical training across three continents. He undertook advanced interventional cardiology and structural heart disease fellowships in the UK and the USA before his appointment at Queen Elizabeth Hospital, Birmingham UK. Dr. Nadir firmly believes in a patient-centered approach and practices shared-decision making to give his patients the confidence in treatment options available to them. In his free time, he is kept busy by his young family and permaculture gardening while (occasionally) indulging in cycling, landscape photography, and skiing. 

View full profile

Seeing is Believing – The Edwards Mitral & Tricuspid Transcatheter Portfolio: Chapterised Sessions

Published: 11 November 2021

  • Views:

    Views Icon 4858
  • Likes:

    Heart Icon 7

Overview

Full programme

Part of

Overview

More from this programme

Tips and Tricks in Imaging Your Patients With Valvular Heart Disease – Aortic Stenosis, Mitral Regurgitation and Tricuspid Regurgitation

Published: 24 June 2021

  • Views:

    Views Icon 7598
  • Likes:

    Heart Icon 7

Overview

Full programme

Part of

Overview

More from this programme

Subscribe to